问答：龙沙斯坦工厂大规模商业扩张——Fierce Pharma报道
Q&A: Large-scale commercial expansion at Lonza’s Stein facility - Fierce Pharma
#Large-scale commercial#Fierce Pharma#Stein facility#commercial expansion#facility Fierce
生命科学资讯
生物技术与制药领域的最新动态
龙沙集团将收购快速微生物检测公司Redberry SAS——激烈生物科技
Lonza to buy rapid microbial testing firm Redberry SAS - Fierce Biotech
#Redberry SAS#Fierce Biotech#firm Redberry#SAS Fierce#buy rapid
Friendswood的Bristol即将动工；Lonza计划翻新Pearland设施 - 社区影响 | 新闻
Bristol in Friendswood to break ground in coming months; Lonza plans renovation in Pearland - Community Impact | News
#Community Impact#Lonza plans#coming months#Pearland Community#break ground
龙沙集团将收购红莓SAS——合同制药
Lonza to Acquire Redberry SAS - Contract Pharma
#Acquire Redberry#Redberry SAS#Contract Pharma#SAS Contract#Pharma Lonza
龙沙集团收购红莓公司以扩大生物科学检测服务范围——药物发现新闻
Lonza to expand bioscience testing offering with the acquisition of Redberry - Drug Discovery News
#Drug Discovery#Redberry Drug#expand bioscience#bioscience testing#testing offering
龙沙确认与美国生物制药基地达成“长期商业供应协议”——Investing.com
Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site - Investing.com
#Lonza confirms#long-term commercial#supply agreement#biologic drug#commercial supply
收益电话会议记录：龙沙集团2025年第三季度CDMO业务强劲增长 - Investing.com
Earnings call transcript: Lonza Group Q3 2025 sees strong CDMO growth - Investing.com
#Lonza Group#strong CDMO#call transcript#CDMO growth#Earnings call
龙沙新购加州生物制剂厂在销售反弹中扮演关键角色——Fierce Pharma报道
Lonza's recently purchased Calif. biologics site plays key role in sales rebound - Fierce Pharma
#purchased Calif#Lonza recently#Calif#recently purchased#Fierce Pharma
龙沙集团公布2025年第三季度业绩强劲，并确认全年展望——TipRanks
Lonza Reports Strong Q3 2025 and Confirms Full-Year Outlook - TipRanks
#Reports Strong#Lonza Reports#Confirms Full-Year#Full-Year Outlook#Strong
龙沙集团2025年第三季度业绩强劲，并确认其CDMO与CHI业务全年展望——TradingView
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses - TradingView
#CHI Businesses#Confirms Full-Year#Lonza Delivers#Businesses TradingView#TradingView Lonza
龙沙确认前景预期，预计未来数月将获更多合同——路透社
Lonza confirms outlook as it expects more contracts in coming months - Reuters
#Lonza confirms#confirms outlook#coming months#Reuters Lonza#months Reuters
龙沙集团获瑞士药监局批准在施泰因设立高效生物制剂药品灌装生产线 - 科技网络
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - Technology Networks
#Technology Networks#Receives Swissmedic#Swissmedic Approval#Highly Potent#Potent Biologics
CPHI 2025：龙沙Capsugel聚焦营养保健品递送技术与可持续发展——营养洞察网报道
CPHI 2025: Lonza Capsugel spotlights delivery tech and sustainability in nutraceuticals - nutritioninsight.com
#Lonza Capsugel#Capsugel spotlights#spotlights delivery#delivery tech#nutritioninsight.com CPHI
GBCC与龙沙合作启动学徒计划——新罕布什尔商业评论
GBCC and Lonza partner for apprenticeship program - NH Business Review
#Business Review#Lonza partner#Review GBCC#apprenticeship program#Lonza
龙沙扩大其细胞与基因疗法GMP解决方案——精选科学报道
Lonza expands its GMP solutions for cell and gene therapy - SelectScience
#GMP solutions#Lonza expands#gene therapy#GMP#SelectScience Lonza
Lonza Capsugel推出有机素食胶囊系列——供应方补充期刊
Lonza Capsugel launches organic, vegan capsule line - SupplySide Supplement Journal
#Supplement Journal#Lonza Capsugel#Capsugel launches#launches organic#vegan capsule
龙沙获瑞士药监局批准在斯坦因（瑞士）设立高效生物制剂药品灌装生产线 - the-scientist.com
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - the-scientist.com
#Lonza Receives#Receives Swissmedic#Swissmedic Approval#Highly Potent#Potent Biologics
现在是审视龙沙集团股份公司（VTX:LONN）的良机吗？——雅虎财经
Is Now An Opportune Moment To Examine Lonza Group AG (VTX:LONN)? - Yahoo Finance
#Opportune Moment#Examine Lonza#Lonza Group#VTX#LONN
龙沙集团：增长迹象与估值过高，新管理层带来不确定性 - 寻求阿尔法
Lonza Group: Growth, Signs Of Overvaluation, And A New Management Cause Uncertainty - Seeking Alpha
#Lonza Group#Seeking Alpha#Uncertainty Seeking#Growth#Alpha Lonza
龙沙集团在瑞士斯坦完成新药品灌装生产线建设——合同制药报道
Lonza Completes New Drug Product Filling Line in Stein, Switzerland - Contract Pharma
#Drug Product#Product Filling#Filling Line#Contract Pharma#Lonza Completes